Michio Sata

Michio Sata's AcademicInfluence.com Rankings

Michio Sata

Philosophy

#6835

World Rank

#9942

Historical Rank

Logic

#3938

World Rank

#5171

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Michio Sata's Degrees

Doctorate Medicine University of Tokyo
PhD Medicine University of Tokyo

Why Is Michio Sata Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michio Sata's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan (1999) (1092)
Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy (2000) (741)
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. (1997) (627)
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. (2006) (583)
Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. (2004) (554)
Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection (2014) (538)
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan (2001) (424)
Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation (1999) (397)
Cis3/Socs3/Ssi3 Plays a Negative Regulatory Role in Stat3 Activation and Intestinal Inflammation (2001) (387)
Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological Factors (2008) (335)
Branched‐chain amino acids as pharmacological nutrients in chronic liver disease (2011) (275)
Clearance of HCV Improves Insulin Resistance, Beta-Cell Function, and Hepatic Expression of Insulin Receptor Substrate 1 and 2 (2007) (266)
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation (2002) (248)
Probiotic Lactobacillus‐induced improvement in murine chronic inflammatory bowel disease is associated with the down‐regulation of pro‐inflammatory cytokines in lamina propria mononuclear cells (2005) (243)
Interferon therapy prolonged life expectancy among chronic hepatitis C patients. (2002) (243)
GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION) (2010) (235)
Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine‐treated rats (2000) (230)
Expression and Role of Vascular Endothelial Growth Factor in Liver Regeneration After Partial Hepatectomy in Rats (2001) (216)
Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble–IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model (2009) (208)
Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. (2006) (207)
Lichen planus and hepatitis C virus in the Northern Kyushu region of Japan (1995) (183)
Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. (1998) (177)
SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis (2004) (177)
Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. (2007) (163)
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009) (2010) (162)
Dipeptidyl peptidase-4: a key player in chronic liver disease. (2013) (158)
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C (2004) (158)
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis (2002) (157)
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors (2006) (156)
Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. (2004) (153)
Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone‐induced cell‐cycle arrest in human hepatoma cell lines (2001) (149)
Role of hepatocytes in direct clearance of lipopolysaccharide in rats. (1995) (141)
Vascular endothelial growth factor in patients with rheumatoid arthritis. (1998) (136)
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon (2005) (134)
The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma (2014) (132)
Nuclear DNA fragmentation and expression of Bcl‐2 in primary biliary cirrhosis (1997) (130)
Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial (2002) (127)
Distribution of Hepatitis B Virus Genotypes among Patients with Chronic Infection in Japan Shifting toward an Increase of Genotype A (2009) (124)
Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. (2003) (124)
Long‐term results of balloon‐occluded retrograde transvenous obliteration for gastric fundal varices: Hepatic deterioration links to portosystemic shunt syndrome (2010) (123)
Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. (2001) (120)
Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. (2000) (119)
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice (2006) (119)
Helicobacter pylori in the natural environment. (1999) (116)
Ito cell contraction in response to endothelin‐1 and substance P (1993) (114)
Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients (2014) (114)
Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. (2011) (113)
Meta‐analysis: insulin resistance and sustained virological response in hepatitis C (2011) (110)
Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation (2006) (109)
Serum hyaluronate reflects hepatic sinusoidal capillarization. (1993) (108)
Balloon‐occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension (2003) (108)
Interleukin-6 trans-signaling in inflammatory bowel disease. (2006) (107)
Empty virus‐like particle‐based enzyme‐linked immunosorbent assay for antibodies to hepatitis E virus (2000) (107)
Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. (1998) (106)
Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment (2003) (100)
Endothelial progenitor cell transplantation improves the survival following liver injury in mice. (2006) (99)
HBV and HCV infection in Japanese dental care workers. (2008) (99)
Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. (2004) (97)
Serum C‐reactive protein levels predict survival in hepatocellular carcinoma (2007) (96)
Insulin resistance and chronic liver disease. (2011) (96)
Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. (2008) (95)
Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis (2001) (94)
Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. (2004) (93)
Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. (2001) (93)
Changes in melatonin concentrations during IFN therapy. (1999) (91)
Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. (2013) (89)
High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. (1995) (86)
Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial. (2009) (86)
Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis. (2014) (85)
Fenofibrate treatment in patients with primary biliary cirrhosis (2002) (82)
Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection (2010) (82)
Hydrogen peroxide overproduction in megamitochondria of troglitazone‐treated human hepatocytes (2003) (81)
Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C (1996) (81)
The endothelin-1 binding site in rat liver tissue: light- and electron-microscopic autoradiographic studies. (1993) (80)
Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. (2003) (78)
Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of β1 integrins (2001) (77)
Troglitazone induces p27Kip1‐associated cell‐cycle arrest through down‐regulating Skp2 in human hepatoma cells (2003) (73)
Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel disease. (2006) (72)
Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. (1993) (72)
Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. (2001) (72)
A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients. (2000) (70)
Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules? (2004) (70)
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. (2006) (69)
Cell cycle regulation by the Wee1 Inhibitor PD0166285, Pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line (2006) (69)
Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease. (2007) (69)
Angiogenic cell therapy for hepatic fibrosis (2006) (68)
Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endothelial cells in rats with liver cirrhosis. (1996) (68)
Role of ATP7B in biliary copper excretion in a human hepatoma cell line and normal rat hepatocytes. (2000) (67)
Interleukin-10 in the Pathophysiology of Inflammatory Bowel Disease: Increased Serum Concentrations During the Recovery Phase (2006) (66)
High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications (2000) (66)
Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus (1996) (65)
Oxidative stress induces the endoplasmic reticulum stress and facilitates inclusion formation in cultured cells. (2007) (64)
Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization. (2010) (63)
Higher elimination rate of hepatitis C virus among women (1996) (63)
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis (2010) (63)
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan (2004) (62)
Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan (2005) (62)
Serum Vascular Endothelial Growth Factor Levels in Various Liver Diseases (2004) (62)
Pneumomediastinum is a frequent but minor complication during esophageal endoscopic submucosal dissection. (2009) (61)
Periostin and bone marrow fibrosis (2008) (61)
Basic fibroblast growth factor regulates proliferation and motility of human hepatoma cells by an autocrine mechanism. (1997) (61)
A mutation of the Wilson disease protein, ATP7B, is degraded in the proteasomes and forms protein aggregates. (2001) (59)
Efficacy and safety of entecavir in lamivudine‐refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients (2008) (58)
Significance of interleukin-6 in patients with inflammatory bowel disease (1991) (56)
Routes of Transimission of Hepatitis C Virus in an Endemic Rural Area of Japan Molecular Epidemiologic Study of Hepatitis C Virus Infection (1997) (55)
Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis (2000) (55)
High expression of insulin‐like growth factor binding protein‐3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma (2006) (54)
Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. (2006) (54)
A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. (2008) (54)
Altered expression of glucagon‐like peptide‐1 and dipeptidyl peptidase IV in patients with HCV‐related glucose intolerance (2008) (54)
Prophylactic Lamivudine Administration Prevents Exacerbation of Liver Damage in HBe Antigen Positive Patients with Hepatocellular Carcinoma Undergoing Transhepatic Arterial Infusion Chemotherapy (2004) (53)
Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis. (2013) (53)
A Decrease in AFP Level Related to Administration of Interferon in Patients with Chronic Hepatitis C and a High Level of AFP (2006) (52)
Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: Immunohistochemical evidence (1993) (52)
Biliary Copper Excretion in Acutely and Chronically Copper‐loaded Rats (1993) (52)
Clinical and pathological features, and the mechanism of development in severe alcoholic hepatitis, especially in comparison with acute type fulminant hepatitis. (1993) (52)
Hepatic stellate cells and intralobular innervation in human liver cirrhosis. (1997) (52)
Structure-function relationships of PEDF. (2010) (51)
Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases (1996) (51)
Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan. (2005) (51)
Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. (2014) (51)
High incidence of oral lichen planus in an HCV hyperendemic area. (2000) (51)
A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease. (2012) (50)
Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area (2012) (50)
Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy. (2007) (50)
Light microscopic findings of liver biopsy specimens from patients with hepatitis type A and comparison with type B. (1982) (50)
The Wilson disease protein ATP7B resides in the late endosomes with Rab7 and the Niemann-Pick C1 protein. (2005) (50)
Prognostic significance of the F‐box protein Skp2 expression in diffuse large B‐cell lymphoma (2003) (50)
Use of HOMA‐IR in hepatitis C (2011) (49)
Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals (2016) (49)
Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. (2003) (49)
Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study (2011) (49)
Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load (2007) (48)
Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis. (1999) (48)
Phase I clinical study of a peptide vaccination for hepatitis C virus‐infected patients with different human leukocyte antigen‐class I‐A alleles (2009) (47)
Different lobular distributions of altered hepatocyte tight junctions in rat models of intrahepatic and extrahepatic cholestasis (1999) (47)
Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy (2012) (46)
The des‐γ‐carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma (2003) (46)
Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update (2012) (46)
Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C. (2005) (46)
Pigment epithelium-derived factor (PEDF) ameliorates advanced glycation end product (AGE)-induced hepatic insulin resistance in vitro by suppressing Rac-1 activation. (2008) (46)
Hepatitis C Virus RNA Detection in Oral Lichen Planus Tissue (1998) (46)
Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection (2003) (45)
Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection (2014) (45)
Histological improvement of oral Lichen planus in patients with chronic hepatitis C treated with interferon. (1999) (45)
Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen. (1992) (44)
Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas. (1999) (44)
The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease (2018) (44)
Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A. (1995) (43)
Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings (2006) (43)
Proteasome inhibition induces inclusion bodies associated with intermediate filaments and fragmentation of the Golgi apparatus. (2003) (41)
Hepatitis C virus and lichen planus (2004) (41)
Inhibition of proteasome‐dependent degradation of Wee1 in G2‐arrested Hep3B cells by TGFβ1 (2003) (41)
Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes. (2005) (40)
Sub-classification of type VI pit patterns in colorectal tumors: relation to the depth of tumor invasion. (2008) (40)
Interleukin‐5 participates in the pathogenesis of ileitis in SAMP1/Yit mice (2004) (40)
A Randomized Study of Extended Treatment With Peginterferon α-2b Plus Ribavirin Based on Time to HCV RNA Negative–Status in Patients With Genotype 1b Chronic Hepatitis C (2009) (40)
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1 (2012) (40)
Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan (2010) (39)
Effects of extracellular matrices on tube formation of cultured rat hepatic sinusoidal endothelial cells (1995) (39)
Vitronectin in liver disorders: Biochemical and immunohistochemical studies (1992) (39)
Nutritional assessments for ordinary medical care in patients with chronic liver disease (2013) (39)
Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. (2011) (39)
Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition. (2009) (39)
Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection (1996) (39)
Endoscopic discrimination of sessile serrated adenomas from other serrated lesions. (2011) (39)
Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats. (2000) (39)
Identification of Peptide Vaccine Candidates Sharing among HLA-A3+, -A11+, -A31+, and -A33+ Cancer Patients (2004) (39)
Ratio of serum vascular endothelial growth factor to platelet count correlates with disease activity in a patient with POEMS syndrome. (2002) (38)
Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study. (2005) (38)
The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma. (2010) (38)
Transgenic over‐expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis (2005) (38)
High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection (1997) (38)
Increased Circulating Concentrations of Growth-Related Oncogene (GRO)-α in Patients with Inflammatory Bowel Disease (2006) (37)
Hepatitis C virus RNA present in saliva but absent in breast‐milk of the hepatitis C carrier mother (1997) (37)
Case–control study for the identification of virological factors associated with fulminant hepatitis B (2009) (37)
Coordinated expression of integrin α6β1 and laminin in hepatocellular carcinoma (1997) (37)
Branched‐chain amino acids improve insulin resistance in patients with hepatitis C virus‐related liver disease: report of two cases (2007) (37)
Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma. (2013) (37)
Suppression of transforming growth factor-beta results in upregulation of transcription of regeneration factors after chronic liver injury. (2004) (36)
Clinical features of hepatitis C virus‐related hepatocellular carcinoma and their association with α‐fetoprotein and protein induced by vitamin K absence or antagonist‐II (2006) (36)
Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPases, inhibits the receptor-mediated endocytosis of asialoglycoproteins in isolated rat hepatocytes. (1996) (36)
Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. (1997) (36)
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels (2013) (35)
Differences of Hepatocellular Carcinoma Patients with Hepatitis B Virus Genotypes of Ba, Bj or C in Japan (2005) (35)
Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection. (2007) (35)
Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma (2012) (35)
Intra‐arterial therapy with cisplatin suspension in lipiodol and 5‐fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis (2010) (35)
Mechanical stretch induces TGF-beta synthesis in hepatic stellate cells. (2004) (35)
Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC. (2003) (35)
The extracellular matrix in hepatocellular carcinoma shows different localization patterns depending on the differentiation and the histological pattern of tumors: immunohistochemical analysis. (1994) (35)
Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif) (2000) (35)
Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice (2012) (35)
Copper does not alter the intracellular distribution of ATP7B, a copper-transporting ATPase. (2000) (34)
Detection of hepatitis A antigen in human liver (1982) (34)
Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report (2012) (34)
Bafilomycin A1, a specific inhibitor of V-type H+-ATPases, inhibits the acidification of endocytic structures and inhibits horseradish peroxidase uptake in isolated rat sinusoidal endothelial cells. (2008) (34)
Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review (2012) (34)
Pigment epithelium‐derived factor (PEDF) inhibits advanced glycation end product (AGE)‐induced C‐reactive protein expression in hepatoma cells by suppressing Rac‐1 activation (2006) (34)
In vitro study of neutrophil apoptosis in liver cirrhosis. (1998) (34)
Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance. (2009) (33)
Immunohistochemistry of the hepatic extracellular matrix in acute viral hepatitis (1990) (33)
A form of circulating interleukin‐6 receptor component soluble gp130 as a potential interleukin‐6 inhibitor in inflammatory bowel disease (2006) (32)
Usefulness of the high-frequency ultrasound probe in pretherapeutic staging of superficial-type colorectal tumors. (1998) (32)
Daclatasvir Combined with Peginterferon Alfa-2A and Ribavirin in Japanese Patients Infected with Hepatitis C Genotype 1 (2014) (32)
Integrin α6β1 plays a significant role in the attachment of hepatoma cells to laminin (1999) (32)
High incidence of extrahepatic manifestations in an HCV hyperendemic area. (2002) (32)
Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan (2002) (31)
Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes. (2013) (31)
Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection (2011) (31)
Copper incorporation into ceruloplasmin is regulated by Niemann–Pick C1 protein (2011) (31)
A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma (2011) (31)
Autoimmune pancreatitis presenting with IgG4-positive multiple gastric polyps. (2010) (31)
A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus (2012) (31)
Insulin resistance and lichen planus in patients with HCV‐infectious liver diseases (2008) (30)
Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases. (1996) (30)
High incidence of multiple primary carcinomas in HCV-infected patients with oral squamous cell carcinoma. (2009) (30)
Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL). (2004) (30)
Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system (2014) (30)
Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor‐κB/hypoxia‐inducible factor‐1α axis under hypoxic conditions (2012) (29)
Estrogen upregulates nitric oxide synthase expression in cultured rat hepatic sinusoidal endothelial cells. (2001) (29)
Mechanism of Entecavir Resistance of Hepatitis B Virus with Viral Breakthrough as Determined by Long-Term Clinical Assessment and Molecular Docking Simulation (2009) (29)
Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma (2014) (29)
Cultured rat hepatic sinusoidal endothelial cells express intercellular adhesion molecule-1 (ICAM-1) by tumor necrosis factor-α or interleukin-1α stimulation (1994) (28)
The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. (2003) (28)
Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection. (1997) (28)
An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis (2016) (28)
Epidemiological study on food intake and Helicobacter pylori infection. (2000) (28)
Genome‐Wide Association Study Identifies Risk Variants for Lichen Planus in Patients With Hepatitis C Virus Infection (2017) (27)
Extrahepatic manifestations and insulin resistance in an HCV hyperendemic area. (2005) (27)
X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues. (2007) (27)
Aggregation and loss of cytokeratin filament networks inhibit golgi organization in liver-derived epithelial cell lines. (2004) (27)
Switching in discoid domain receptor expressions in SLUG‐induced epithelial‐mesenchymal transition (2008) (27)
Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue. (2009) (27)
Effect of oral care gel on the quality of life for oral lichen planus in patients with chronic HCV infection (2011) (26)
Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts (2008) (26)
Effect of interferon treatment on serum 2′,5′‐oligoadenylate synthetase levels in hepatitis C‐infected patients (2000) (26)
Surveillance Program for Early Detection of Hepatocellular Carcinoma in Japan: Results of Specialized Department of Liver Disease (2006) (26)
Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection. (2004) (25)
Early therapy with interferon for acute hepatitis C acquired through a needlestick. (1997) (25)
Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study (2012) (25)
Attenuation of experimental colonic injury by thiazolidinedione agents (2005) (25)
Unusual accumulation of glycogen in liver parenchymal cells in a patient with anorexia nervosa. (1998) (25)
Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis (2005) (25)
Serum albumin level is a notable profiling factor for non‐B, non‐C hepatitis virus‐related hepatocellular carcinoma: A data‐mining analysis (2014) (25)
Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: a prospective study. (1997) (25)
A case of mediastinal pancreatic pseudocyst successfully treated with somatostatin analogue. (2005) (25)
GB virus infection in patients with oral cancer and oral lichen planus. (1997) (25)
Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. (2006) (25)
Recent Progress in the Diagnosis and Therapy for Veno-occlusive Disease of the Liver (2003) (25)
Mutation in keratin 18 induces mitochondrial fragmentation in liver-derived epithelial cells. (2008) (25)
Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers. (2011) (24)
Activation of c‐Jun N‐terminal kinase (JNK) signalling in experimentally induced gastric lesions in rats (2006) (24)
Epidemiological survey of oral lichen planus among HCV-infected inhabitants in a town in Hiroshima Prefecture in Japan from 2000 to 2003. (2007) (24)
Wilson disease protein ATP7B is localized in the late endosomes in a polarized human hepatocyte cell line. (2003) (24)
Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Advanced Glycation End-product (AGE)-elicited Hepatic Insulin Resistance via Peroxisome Proliferator-activated Receptor-γ Activation (2008) (24)
Laminin deposition to type IV collagen enhances haptotaxis, chemokinesis, and adhesion of hepatoma cells through beta1-integrins. (2001) (24)
A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine (2003) (24)
Human peripheral blood CD34‐positive cells enhance therapeutic regeneration of chronically injured liver in nude rats (2012) (23)
Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B (2009) (23)
PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells. (2011) (23)
Metronomic S-1 chemotherapy and vandetanib: an efficacious and nontoxic treatment for hepatocellular carcinoma. (2011) (23)
Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride‐induced rat liver cirrhotic model (2013) (23)
A case report of primary hepatic squamous cell carcinoma that remarkably responded to low dose arterial injection of anti-cancer drugs. (2003) (23)
Prevention of liver fibrosis and liver reconstitution of DMN‐treated rat liver by transplanted EPCs (2012) (23)
Integrin alpha6beta1 plays a significant role in the attachment of hepatoma cells to laminin. (1999) (23)
Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma? (1998) (22)
Two fatal cases of hepatitis B virus carriers after corticosteroid therapy for bronchial asthma. (1992) (22)
Extended indication criteria for endoscopic mucosal resection of early gastric cancer with special reference to lymph node metastasis--examination by multivariate analysis. (2004) (22)
Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report (2016) (22)
Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B (2010) (22)
Preventive effects of enzyme-treated rice fiber in a restraint stress-induced irritable bowel syndrome model. (2010) (22)
CD34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis (2014) (22)
The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey (2014) (22)
Niemann-Pick C1 protein transports copper to the secretory compartment from late endosomes where ATP7B resides. (2009) (22)
The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment. (1998) (21)
Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells. (2010) (21)
Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy. (1997) (21)
Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices. (2008) (21)
Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro‐carcinogenesis in chronic hepatitis C (2013) (21)
A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C. (2003) (21)
The significance of colocalization of plasminogen activator inhibitor-1 and vitronectin in hepatic fibrosis. (1997) (21)
Mutations in the NS5A gene predict response to interferon therapy in Japanese patients with chronic hepatitis C and cirrhosis. (1999) (21)
A cohort study of chronic liver disease in an HCV hyperendemic area of Japan: a prospective analysis for 12 years. (2004) (21)
Atypical manifestations of pancreatitis with autoimmune phenomenon in an adolescent female. (2005) (21)
Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease. (2014) (20)
Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial (2009) (20)
SEVERE HEPATOTOXICITY ASSOCIATED WITH A N‐NITROSOFENFLURAMINE‐CONTAINING WEIGHT‐LOSS SUPPLEMENT: REPORT OF THREE CASES (2004) (20)
Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties. (2013) (20)
Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy. (2004) (20)
Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid‐associated osteoporosis in patients with ulcerative colitis (2009) (20)
Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan (1998) (20)
Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study. (2015) (20)
Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C (2010) (20)
[Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia]. (2004) (19)
A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C. (2006) (19)
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan. (2013) (19)
The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area (2011) (19)
Clinical evaluation of four cases of acute viral hepatitis complicated by pure red cell aplasia. (1994) (19)
Depletion of endothelial progenitor cells in the peripheral blood of patients with ulcerative colitis. (2007) (19)
Electron microscopic observation of established chondrocytes derived from human intervertebral disc hernia (KTN-1) and role of macrophages in spontaneous regression of degenerated tissues. (2001) (19)
Transcription Factor-Targeted Therapies in Inflammatory Bowel Disease (2001) (19)
Decreased expression of insulin and increased expression of pancreatic transcription factor PDX-1 in islets in patients with liver cirrhosis: a comparative investigation using human autopsy specimens (2013) (18)
Functional differences between hepatocytes and biliary epithelial cells in handling polymeric immunoglobulin A2 in humans, rats, and guinea pigs (1996) (18)
Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease (2008) (18)
Effect of Helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension (2013) (18)
Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression. (1996) (18)
CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma. (1997) (18)
Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C (2010) (18)
Increased serum IgM class anti-lipid A antibody and therapeutic effect of ursodeoxycholic acid in primary biliary cirrhosis. (1994) (18)
Biological responses to administered interferon in alcoholics. (1996) (18)
Coordinated expression of integrin alpha6beta1 and laminin in hepatocellular carcinoma. (1997) (18)
Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan. (2005) (18)
High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors (2015) (18)
Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan. (2003) (18)
Efficacy of Vascular Endothelial Growth Factor in the Treatment of Experimental Gastric Injury (2002) (17)
Lipid profile is associated with the incidence of cognitive dysfunction in viral cirrhotic patients: A data‐mining analysis (2013) (17)
Branched-chain amino acids enhance cyst development in autosomal dominant polycystic kidney disease. (2017) (17)
Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action. (2009) (17)
Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases (2012) (17)
High prevalence of anticardiolipin antibodies in patients with HCV-associated oral lichen planus. (2002) (17)
Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene. (2003) (17)
High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma (1997) (17)
Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy (2004) (17)
Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B (1997) (17)
Endoscopic ultrasonographic study of autoimmune pancreatitis and the effect of steroid therapy (2012) (17)
Role of cytoskeleton and acidification of endocytic compartment in asialoglycoprotein metabolism in isolated rat hepatocyte couplets (1995) (17)
Hybrid training of voluntary and electrical muscle contractions decreased fasting blood glucose and serum interleukin-6 levels in elderly people: a pilot study. (2011) (17)
Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line. (2004) (16)
Mobilization of Human Lymphoid Progenitors after Treatment with Granulocyte Colony-Stimulating Factor 1 (2005) (16)
Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography: report of a case and successful treatment of the patient with prednisolone and cyclophosphamide (1999) (16)
Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non‐hepatitis B virus/non‐hepatitis C virus‐related hepatocellular carcinoma (2011) (16)
Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases (1995) (16)
Prognostic benefit in cytoreductive surgery for curatively unresectable hepatocellular carcinoma - comparison to transcatheter arterial chemoembolization. (1999) (16)
Value of Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein for Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment (2013) (16)
Indication for Endoscopic Resection of Submucosal Colorectal Carcinoma: Special Reference to Lymph Node Metastasis (2000) (16)
Keratin-containing inclusions affect cell morphology and distribution of cytosolic cellular components. (2005) (16)
Abnormal accumulation in lipopolysaccharide in biliary epithelial cells of rats with self-filling blind loop. (2002) (16)
Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine. (2001) (16)
Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen (2005) (16)
Relaxing effect of interleukin‐1 on rat cultured Ito cells (1997) (16)
Ursodeoxycholic acid reduces expression of heat shock proteins in primary biliary cirrhosis. (2000) (16)
Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease. (2009) (16)
Association of HLA-DRB1 0803 and 1602 with the susceptibility to primary biliary cirrhosis (1995) (15)
Role of serum interleukin-8 and intercellular adhesion molecule-1 in the severity of alcoholic hepatitis. (1994) (15)
Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma. (1996) (15)
Organ-specific autoimmunity in mice whose T cell repertoire is shaped by a single antigenic peptide. (2001) (15)
Erythropoietic protoporphyria with fatal liver failure (1999) (15)
Roles of high-mobility group box 1 in murine experimental colitis. (2008) (15)
Oral cancer and hepatitis C virus (HCV): can HCV alone cause oral cancer?--a case report. (1996) (15)
Exendin‑4, a glucagon‑like peptide‑1 receptor agonist, modulates hepatic fatty acid composition and Δ‑5‑desaturase index in a murine model of non‑alcoholic steatohepatitis. (2014) (15)
A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin. (1995) (15)
Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study. (2006) (14)
Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies (2003) (14)
Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C (2002) (14)
The prognosis for life in an HCV hyperendemic area. (2003) (14)
High plasma cardiac natriuretic peptides associated with enhanced cyclic guanosine monophosphate production in preascitic cirrhosis. (2000) (14)
Pathological characteristics of patients who develop hepatocellular carcinoma with negative results of both serous hepatitis B surface antigen and hepatitis C virus antibody (2014) (14)
Usefulness of lavage cytology during endoscopic transpapillary catheterization into the gallbladder in the cytological diagnosis of gallbladder disease (2009) (14)
Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy (2010) (14)
Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders. (2010) (14)
A case of malignant lymphoma with hemophagocytic syndrome presenting as hepatic failure. (1997) (14)
Monitoring of serum levels of HCV RNA in early phase of IFN therapy; as a predictive marker of subsequent response. (1998) (14)
Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity (2004) (13)
THE MANAGEMENT OF THE PANCREATIC CYSTIC NEOPLASM: THE ROLE OF THE EUS IN JAPAN (2011) (13)
Alpha-fetoprotein- and des-gamma-carboxy prothrombin-producing advanced gastric cancer (2002) (13)
Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report. (2003) (13)
Effect of a Late Evening Snack of Amazake in Patients with LiverCirrhosis: A Pilot Study (2013) (13)
Lamivudine treatment‐related morphological changes of esophageal varices in patients with liver cirrhosis (2007) (13)
Subjective global assessment is not sufficient to screen patients with defective hepatic metabolism. (2011) (13)
Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma. (2001) (13)
Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: a new biomarker for overall survival of patients with malignant diseases. (2013) (13)
Mobilization of Bone Marrow Cells by Leukocytapheresis in Patients With Ulcerative Colitis (2008) (13)
Pigment epithelium-derived factor (PEDF) blocks the interleukin-6 signaling to C-reactive protein expression in Hep3B cells by suppressing Rac-1 activation. (2006) (13)
The possible intraspousal transmission of HCV in terms of lichen planus. (2002) (13)
Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C (2006) (13)
An experimental animal model of primary biliary cirrhosis induced by lipopolysaccharide and pyruvate dehydrogenase. (1996) (13)
Partial spontaneous regression of hepatocellular carcinoma: a case with high concentrations of serum lens culinaris agglutinin-reactive alpha fetoprotein. (2005) (13)
Antibody Reactive to a Hepatitis C Virus (HCV)‐Derived Peptide Capable of Inducing HLA‐A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV‐Infected Individuals without HLA‐A2 Restriction (2004) (13)
Methylated-(3′′)-Epigallocatechin Gallate Analog Suppresses Tumor Growth in Huh7 Hepatoma Cells Via Inhibition of Angiogenesis (2014) (13)
Aging Modulates Susceptibility to Mouse Liver Mallory-Denk Body Formation (2012) (13)
Leukocytapheresis for the treatment of active pouchitis: a pilot study (2008) (13)
Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis (2013) (13)
Balloon-occluded retrograde transvenous obliteration versus endoscopic injection sclerotherapy for isolated gastric varices: a comparative study. (2014) (13)
Dental problems delaying the initiation of interferon therapy for HCV-infected patients (2010) (13)
Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C. (1995) (13)
Serum level of free fatty acids is associated with nocturnal hypoglycemia in cirrhotic patients with HCV infection: a pilot study. (2011) (13)
Chemotherapy for hepatocellular carcinoma with portal hypertension due to tumor thrombus. (2000) (12)
STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury (2017) (12)
Colour Doppler ultrasonography of a segmental branch of the portal vein is useful for early diagnosis and monitoring of the therapeutic course of veno‐occlusive disease after allogenic haematopoietic stem cell transplantation (2001) (12)
GB virus C (GBV-C)/hepatitis G virus (HGV) infection among intravenous drug users in Japan. (1997) (12)
Fatal acute hepatitis B virus infection while receiving immunosuppressants after renal transplantation. (1993) (12)
Aortitis syndrome (Takayasu's arteritis) with cataract and elevated serum level of vascular endothelial growth factor. (1998) (12)
Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension. (2014) (12)
Timing of interferon therapy and sources of infection in patients with acute hepatitis C. (2006) (12)
Aminofeel improves the sensitivity to taste in patients with HCV-infected liver disease. (2010) (12)
Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis. (2011) (12)
Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients (2012) (12)
Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial. (2015) (12)
Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients (2012) (12)
Budd-Chiari syndrome complicated by hepatocellular carcinoma with no evidence of infection with hepatitis virus: a case report. (1999) (12)
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma. (2006) (12)
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33 (2007) (12)
Clinical features of cirrhosis in Japanese patients with type I autoimmune hepatitis. (2012) (12)
Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients (2009) (12)
HBV DNA can be detected from nail clippings of HBs Ag positive patients. (2000) (12)
Expression of uncoupling protein-2 in biliary epithelial cells in primary biliary cirrhosis. (2002) (12)
Kinetics of C-reactive protein in acute viral hepatitis (1989) (12)
The pathogenesis, complications and therapeutic strategy for hepatitis C virus-associated insulin resistance in the era of anti-viral treatment. (2010) (11)
A novel strategy for remission induction and maintenance in cancer therapy. (2002) (11)
Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study (2017) (11)
ENDOSCOPIC RETRIEVAL OF MIGRATED PLASTIC STENT INTO BILE DUCT OR PANCREATIC PSEUDOCYST (2009) (11)
Hepatitis B virus genotype G is an extremely rare genotype in Japan. (2004) (11)
Detection of hepatitis-C virus and hepatitis-C virus replication in hepatocellular carcinoma by in situ hybridization. (1999) (11)
Detection of MAGE‐4 Protein in the Sera of Patients with Hepatitis‐C Virus‐associated Hepatocellular Carcinoma and Liver Cirrhosis (1997) (11)
Timing of IFN therapy initiation for acute hepatitis C after accidental needlestick. (1997) (11)
Bright loop appearance; a characteristic ultrasonography sign of early hepatocellular carcinoma. (2000) (11)
Supplement improves nutrition and stresses caused by examination‐associated fasting in patients with liver cirrhosis (2008) (11)
Hydrogen Peroxide Stimulates Pigment Epithelium-derived Factor Gene and Protein Expression in the Human Hepatocyte Cell Line OUMS-29 (2007) (11)
CASE REPORT: Adefovir Dipivoxil as a Treatment for Hepatic Failure Caused by Lamivudine-Resistant HBV Strains (2004) (11)
Ultrastructure of intracellular membranous system and intracellular transport of asialoglycoproteins in rat hepatocytes. (1992) (11)
Markedly prolonged jaundice from simultaneous infection with hepatitis E virus and leptospira. (2003) (11)
Motor vehicle accidents: how should cirrhotic patients be managed? (2012) (11)
Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study (2012) (11)
A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan (2009) (11)
Intestinal microflora as a therapeutic target in inflammatory bowel disease (2002) (11)
OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats. (1999) (10)
Oral verrucous carcinoma arising from lichen planus and esophageal squamous cell carcinoma in a patient with hepatitis C virus-related liver cirrhosis-hyperinsulinemia and malignant transformation: A case report. (2013) (10)
Human primary cultured hepatic stellate cells can be cryopreserved (2010) (10)
Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5‐fluorocytosine administration suppresses growth of 5‐fluorouracil‐sensitive liver cancer in mice (2012) (10)
Long‐term outcome of elderly patients (75 years or older) with hepatocellular carcinoma (2014) (10)
Interferon accumulation in cirrhotic rat liver (1996) (10)
Multiple primary neoplasms and hepatitis C virus infection in oral cancer patients (1997) (10)
Successful treatment of rectal ulcers in a patient with systemic lupus erythematosus using corticosteroids and tacrolimus (2012) (10)
Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis: A Case Report (2004) (10)
Prevalence of hepatitis C antibodies in health care personnel. (1997) (10)
Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study (2014) (10)
Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection. (2013) (10)
Detection of hepatitis C virus in saliva before and after scaling of dental calculus. (2000) (10)
Cytomegalovirus pneumonitis presenting small nodular opacities. (2004) (10)
Clinical characteristics of patients in their 40s with HCV antibody-positive hepatocellular carcinoma. (2000) (10)
Effect of AGEs on human disc herniation: intervertebral disc hernia is also effected by AGEs. (2002) (10)
Intrahepatic cholangiocarcinoma with sarcomatous change producing granulocyte‐colony stimulating factor (2013) (10)
N‐BUTYL‐2‐CYANOACRYLATE (HISTOACRYL) GLUE IN THE RIGHT ATRIUM AFTER ENDOSCOPIC INJECTION FOR A RUPTURED DUODENAL VARIX: COMPLICATION OF HISTOACRYL INJECTION (2012) (10)
Endoscopic ultrasonography staging of superficial-type colorectal neoplasms for mucosectomy. (1998) (9)
Quantification of Hepatic Iron Concentration in Chronic Viral Hepatitis: Usefulness of T2-weighted Single-Shot Spin-Echo Echo-Planar MR Imaging (2012) (9)
Detection of serum HBV DNA and anti-HCV antibody in HBsAg seronegative patients with hepatocellular carcinoma in Japan. (1996) (9)
Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH). (2006) (9)
Immunological evaluation in oral lichen planus with chronic hepatitis C (1997) (9)
Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability. (2007) (9)
Light and electron microscopic analyses of immediate and late tissue damage caused by radiofrequency ablation in porcine liver. (2003) (9)
Thrombocytopenia, an important interfering factor of antiviral therapy and hepatocellular carcinoma treatment for chronic liver diseases. (2009) (9)
Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone. (2002) (9)
Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan (2010) (9)
Possible diagnostic role of antibodies to Crohn’s disease peptide (ACP): results of a multicenter study in a Japanese cohort (2014) (9)
Propranolol ameliorates thrombocytopenia in patients with cirrhosis (2002) (9)
Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis (2013) (9)
Oxidized albumin is associated with water retention and severity of disease in patients with chronic liver diseases (2010) (9)
DIRECT CHOLANGIOSCOPY USING A DOUBLE‐BALLOON ENTEROSCOPE: CHOLEDOCHOJEJUNOSTOMY WITH INTRADUCTAL BILIARY CARCINOMA (2010) (9)
Promyelocytic Crisis of Chronic Myelogenous Leukaemia during Imatinib Mesylate Treatment (2006) (8)
Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma (2017) (8)
Various extrahepatic manifestations caused by hepatitis C virus infection. (1999) (8)
[HCV or HBV infection self-disclosure to dentists]. (2008) (8)
Hyperplastic nodular hepatic lesions following end-to-side portacaval shunting in childhood. (2007) (8)
Quantitative analysis of colorectal mucosal lesions by autofluorescence endoscopy: discrimination of carcinomas from other lesions. (2011) (8)
Role of vascular endothelial growth factor in protein loss of Ménétrier's disease. (2006) (8)
Usefulness of magnifying endoscopy with narrow-band imaging for diagnosis of depressed gastric lesions. (2014) (8)
Relapsing polychondritis associated with subclinical Sjögren's syndrome and phlegmon of the neck. (1995) (8)
Validating a Markov Model of Treatment for Hepatitis C Virus-related Hepatocellular Carcinoma (2008) (8)
Detection of a set of peptide vaccine candidates for use in HLA-A31+ epithelial cancer patients. (2004) (8)
Analysis of factors interfering with the acceptance of interferon therapy by HCV-infected patients. (2008) (8)
Chronic hepatitis C in alcoholic patients: studies with various HCV assay procedures. (1993) (8)
Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes (1998) (8)
Endotoxin increases paracellular permeability of isolated rat hepatocyte couplets. (2001) (8)
Appearance-specific satiety increases appetite and quality of life in patients with metastatic liver tumor: a case report. (2006) (8)
Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels. (2002) (8)
Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient (2012) (8)
Natural disappearance of serum HCV RNA: prospective study in a hyperendemic area (1997) (8)
Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma. (2014) (8)
β1-Integrin mediates cell adhesion, haptotaxis, and chemokinesis of hepatoma cells (1999) (7)
Technique of reintervention for stent dysfunction in patients with malignant hilar biliary stricture (2013) (7)
Cultured rat hepatic sinusoidal endothelial cells express intercellular adhesion molecule-1 (ICAM-1) by tumor necrosis factor-alpha or interleukin-1 alpha stimulation. (1994) (7)
Endotoxin and Kupffer cells in liver disease. (1990) (7)
Ultrastructural observation on hepatocellular carcinoma (1993) (7)
Upright posture blunts postprandial splanchnic hyperemia in patients with cirrhosis and portal hypertension (1999) (7)
Evaluation of Endoscopic Transpapillary Brushing Cytology for the Diagnosis of Bile Duct Cancer Based on the Histopathologic Findings (2014) (7)
Morphological observation on extrahepatic bile duct of golden hamsters fed a lithogenic diet: histochemical, ultrastructural and cell kinetic studies. (1994) (7)
Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels. (2005) (7)
Branched-chain amino acid supplements reduced ascites and increased the quality of life in a patient with liver cirrhosis: A case report. (2009) (7)
Two cases of adult varicella accompanied by hepatic dysfunction. (1998) (7)
A case of chronic hepatitis C with sinus bradycardia during IFN therapy. (1998) (7)
Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report. (2006) (7)
The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma (2012) (7)
Clinical significance of antibody against hepatitis B virus core antigen in patients with hepatitis C virus‐related hepatocellular carcinoma (2003) (7)
Successful treatment for bronchial bleeding from invasive pulmonary metastasis of hepatocellular carcinoma: a case report. (2001) (7)
Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin (2012) (7)
Studies on anti-HCV in hepatocellular carcinoma with alcoholic cirrhosis. (1990) (7)
CLINICAL EVALUATION OF PERORAL CHOLANGIOSCOPY FOR BILIARY DISEASE USING NARROW BAND IMAGING (2007) (7)
A case of acute pancreatitis following endoscopic biopsy of the ampulla of Vater. (2013) (7)
Antineoplaston treatment for advanced hepatocellular carcinoma. (1998) (7)
The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study (2016) (7)
Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment (2005) (7)
Simultaneous Hepatic Relapse of Non-Hodgkin’s Lymphoma and Hepatocellular Carcinoma in a Patient with Hepatitis C Virus-Related Cirrhosis (2006) (7)
SUCCESSFUL ENDOSCOPIC EXTRACTION OF A LARGE IMPACTED CHOLEDOCHOLITHIASIS IN THE AMPULLA OF VATER: TWO INTERESTING CASES (2010) (7)
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection (2004) (7)
Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman (2014) (7)
Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C. (2002) (7)
[Long-term prognosis of Crohn's disease]. (1991) (6)
Vascular endothelial growth factor is involved in angioedema associated with eosinophilia. (2005) (6)
Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012. (2014) (6)
Usefulness of technetium-99m-galactosyl human serum albumin liver scintigraphy for assessment of severity of alcoholic hepatitis. (1996) (6)
Clinical study of acute hepatitis type A in patients older than fifty years. (1988) (6)
Effects of interferon alpha 2a on incidence of hepatocellular carcinoma in chronic active hepatitis without cirrhosis. Hepatitis Treatment Study Group. (1997) (6)
Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection. (2013) (6)
Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan. (2004) (6)
Isolation and characterization of a novel short peptide associated with Crohn's disease (2011) (6)
A patient with chronic hepatitis C and a history of abuse of analeptic drugs, who showed hallucination and delusion with interferon administration. (1996) (6)
[A case of autoimmune pancreatitis complicated with immune thrombocytopenia]. (2006) (6)
Antibody response to inactivated hepatitis A vaccine (1997) (6)
Redox state of albumin is not associated with colloid osmotic pressure. (2010) (6)
Ultrastructure of the intracellular membranous system of rat hepatocytes in intrahepatic cholestasis induced by phalloidin. (1994) (6)
Hepatocellular carcinoma with a "nodule-in-nodule" appearance reflecting an unusual dilated pseudoglandular structure. (2008) (6)
Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis (2009) (6)
Chapter 6 – Cells Responsible for Extracellular Matrix Production in the Liver (2003) (6)
Hydroxyl radical generation and membrane fluidity of erythrocytes treated with lipopolysaccharide. (1993) (6)
Atorvastatin Inhibits Advanced Glycation End Products (AGE)-Induced C-Reactive Expression in Hepatoma Cells by Suppressing Reactive Oxygen Species Generation (2007) (6)
Effects of OK-432 on matrix metalloproteinase-9 expression and activity in rat cultured Kupffer cells (1998) (6)
Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy using technetium-99m-labelled galactosyl human serum albumin. (2011) (6)
Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter study (2013) (5)
[Clinical analysis of cat scratch disease]. (2010) (5)
High Affinity of Ecabet Sodium for Inflamed Colonic Mucosa in Ulcerative Colitis (2007) (5)
Open‐labeled randomized controlled trial to compare diuretic therapy with recombinant human serum albumin and diuretic therapy for therapeutic treatment of ascites in patients with advanced liver cirrhosis: An exploratory trial (2014) (5)
A case of postirradiation angiosarcoma of the greater omentum with hemorrhage (2011) (5)
Contribution of diuretic therapy with human serum albumin to the management of ascites in patients with advanced liver cirrhosis: A prospective cohort study. (2014) (5)
Long-term follow-up of interferon-treated chronic hepatitis C and serum hepatic fibrosis markers. (2001) (5)
Evaluation of endoscopic cytological diagnosis of unresectable pancreatic cancer prior to and after the introduction of endoscopic ultrasound-guided fine-needle aspiration. (2014) (5)
Transmission routes and clinical courses in sporadic acute hepatitis C (1997) (5)
[Hepatitis B vaccination in alcoholics]. (1989) (5)
A 48‐week telaprevir‐based triple combination therapy improves sustained virological response rate in previous non‐responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study (2014) (5)
TRANS‐GASTRIC ENDOSCOPIC DRAINAGE USING A LARGE BALLOON FOR PANCREATIC NECROSIS AND ABSCESS – TWO CASE REPORTS (2009) (5)
Formation of black pigment gallstone in a hamster model of experimental cirrhosis (1997) (5)
Quick response of advanced cancer to chemoradiation therapy with antineoplastons. (1998) (5)
Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients. (2005) (5)
Roles of the splenic cytokines and arachidonic acid metabolites in severe hepatic injury after lipopolysaccharide injection in chronically alcohol-fed rats. (1993) (5)
Fish to meat intake ratio and cooking oils are associated with hepatitis C virus carriers with persistently normal alanine aminotransferase levels (2012) (5)
A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon–ribavirin therapy (2008) (5)
[Infection of C type hepatitis virus in patients with alcoholism. Studied by serum HCV antibody of C100-3 and 2nd generation]. (1992) (5)
Intraspousal transmission of GB virus C/hepatitis G virus in an hepatitis C virus hyperendemic area in Japan (1999) (5)
[Autoimmune thrombocytopenia and erythroid hypoplasia associated with hepatitis A]. (2000) (5)
Evaluation of interferon treatment in cirrhotic patients with hepatitis C. (1996) (5)
Subclones of Drug-Resistant Hepatitis B Virus Mutants and the Outcome of Breakthrough Hepatitis in Patients Treated with Lamivudine (2003) (5)
Effect of Oral Care Gel for Burning Mouth Syndrome in a Patient with Hepatitis C: A Case Report (2017) (5)
The preventive effect of antineoplaston AS2-1 on HCC recurrence. (2003) (5)
Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas. (2001) (5)
Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy. (2005) (5)
Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma. (1998) (5)
Gender difference in alcoholic liver disease in Japan—an analysis based on histological findings (1997) (4)
Analysis of the factors motivating HCV-infected patients to accept interferon therapy (2012) (4)
Involvement of activated polymorphonuclear leukocytes in galactosamine-induced hepatic injury in rats (1991) (4)
Liver‐Associated Natural Killer Activity in Cirrhotic Rats (1998) (4)
Heating improves poor compliance with branched chain amino acid-rich supplementation in patients with liver cirrhosis: A before-after pilot study. (2009) (4)
[Survey of hepatitis B and C in students of faculty of dentistry and dental hygienist school]. (2004) (4)
Mechanisms Underlying the Effects of Leukocyte Apheresis with a Fiber Filter in a Rat Model of Dextran Sulfate Sodium-Induced Colitis (2010) (4)
Clinical efficacy of combination therapy with ME3738 and pegylated interferon‐alpha‐2a in patients with hepatitis C virus genotype 1 (2014) (4)
HCV NS5A 2209-2248 amino acid substitutions affect serum 2,5AS activities. (1999) (4)
Negative-strand HCV RNA was not detected in bone marrow cells of patients with HCV infection. (1998) (4)
Knowledge of Vibrio vulnificus infection among Japanese patients with liver diseases: a prospective multicenter study. (2009) (4)
Analysis of serum hepatitis A virus antibody response in different courses of hepatitis A virus infection (1996) (4)
Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia. (2002) (4)
Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases (2014) (4)
[A case of microscopic polyarteritis nodosa associated with autoimmune hepatitis complicated with rheumatoid arthritis and chronic thyroiditis]. (2000) (4)
Scleroderma and repeated spontaneous abortions treated with vitamin E--a case report--. (2005) (4)
Use of complementary alternative medicines in patients with gastrointestinal diseases (2003) (4)
Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients. (2006) (4)
Selection of prognostic factors of acute hepatitis type non-A, non-B for patient listing for liver transplantation. (1997) (4)
VEGF Participates in Neovascularization and Sinusoidal Capillarization in HCC (1999) (4)
Cytokine-targeted therapeutic approaches for inflammatory bowel disease. (2000) (4)
Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma. (2010) (4)
713 Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease patients: Double-blind placebo-controlled study (2006) (4)
[Case of overwhelming postsplenectomy infection (OPSI) with chronic hepatitis type C during peginterferon/ribavirin combination therapy]. (2009) (4)
Immunoregulatory cytokines and intestinal inflammation (2005) (4)
HCC develops even in the early stage of chronic liver disease in elderly patients with HCV infection. (2010) (4)
Endoscopic ultrasonography-guided cystogastrostomy for large pancreatic pseudocyst with obstructive jaundice--a case report. (2006) (4)
Where is the site that ATP7B transports copper within hepatocytes? (2003) (4)
Serum hyaluronate in liver diseases. (1991) (4)
Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA (1997) (4)
High prevalence of hepatitis C virus infection in schistosomiasis japonica patients associated with hepatocellular carcinoma. (1997) (4)
Quick and simple method for increasing the reduced albumin fraction in human serum albumin preparations by using stronger neo‐minophagen C (2011) (4)
Evaluation of magnifying endoscopy using narrow band imaging using ex vivo bile duct (with video) (2013) (4)
New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA‐A2+ HCV‐Infected Patients (2006) (4)
Long-Term Survival Following Treatment with Antineoplastons for Colon Cancer with Unresectable Multiple Liver Metastases: Report of a Case (2003) (4)
[Bezafibrate alone is an effective first-line therapy for primary sclerosing cholangitis: a case report]. (2006) (4)
Cholestasis in a rat model of graft-versus-host disease is accompanied by alteration of the expression and distribution of tight-junction-associated proteins. (2005) (4)
Beneficial effects of prebiotics, germinated barley foodstuff, in the long term treatment of ulcerative colitis: a multi-center open control study (2003) (3)
Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naïve Genotype 1b Chronic Hepatitis C Patients (2014) (3)
Acute hepatitis A superimposed on liver cirrhosis - A report of four cases. (1985) (3)
Mutations of glucocorticoid responsive element of HBV DNA. (1998) (3)
6. Hepatitis Virus and Extrahepatic Manifestations -Skin, Mucosa, Muscle, and Hematopoietic Organs- (2001) (3)
Results of Percutaneous External Drainage (1984) (3)
Decrease of interferon-induced 2',5'-oligoadenylate synthetase activity in cirrhotic rat liver. (1995) (3)
Radiographic observation of a case of gastrointestinal stromal tumor in stomach. (2001) (3)
Determination of Thrombopoietin‐Derived Peptides Recognized by Both Cellular and Humoral Immunities in Healthy Donors and Patients with Thrombocytopenia (2005) (3)
Incidence of anti-HTLV-1 antibody in liver disease (1992) (3)
Independent factors associated with altered plasma active ghrelin levels in HCV‐infected patients (2013) (3)
Effect of Patient Education Seminars on Awareness and Behavior of Individuals with Viral Liver Disease (2015) (3)
Supplementation before endoscopic therapy for esophageal varices reduces mental stress in patients with liver cirrhosis. (2011) (3)
[A case of chronic renal failure caused hyperkalemia following percutaneous radiofrequency ablation therapy for hepatocellular carcinoma]. (2003) (3)
Clinical evaluation of intramuscular administration of natural interferon-gamma in the treatment of chronic hepatitis B. (1995) (3)
[Two cases of suspected Bartonella henselae infection from a dog]. (1999) (3)
Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice (2006) (3)
Predictive Factors Associated with the Progression to Hepatic Failure Caused by Lamivudine-Resistant HBV (2008) (3)
[A case of hepatic eosinophilic granuloma, which needs distinction with metastatic liver cancer]. (2008) (3)
Change in cerebral blood flow in an acute hepatitis C patient with depressive state while receiving interferon (1996) (3)
Sequence Variation of the Hypervariable Region in HCV Carriers with Normal ALT Levels: A Comparison with Symptomatic Carriers (1996) (3)
Probiotic lactobacillus improved murine chronic IBD through the downregulation of IL-6 production in lamina propria lymphocytes (2003) (3)
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b+ HLA‐A24+ patients (2007) (3)
The mechanism of germinated barley foodstuff in attenuating ntestinal inflammation in colitis (2000) (3)
The reticuloendothelial system and macrophage-monocyte system in thorotrast patients. (1999) (3)
Premalignant Cancer in a Murine Model Development of Colitis-Associated Lamina Propria Macrophages, on the IL-6 Receptor Derived from - IL-6/Soluble Colonic Epithelial Cells, Induced by the -Signaling in Trans Essential Roles of IL-6 (2010) (3)
Reduced contractility and histological changes in the gallbladder due to portal hypertension in a hamster cirrhosis model. (1997) (3)
Microarray analyses of peripheral whole blood cells from ulcerative colitis patients: effects of leukocytapheresis. (2013) (3)
A patient with hepatic granuloma formation and angiotensin‐converting enzyme production by granuloma cells during clinical relapse of hepatitis A (1994) (3)
[A case of respiratory failure caused by pulmonary alveolar hemorrhage in Crohn's disease]. (2004) (3)
Expression of Epithelial Cancer-Related Antigens in Hematologic Malignancies Applicable for Peptide-Based Immunotherapy (2004) (3)
A resected case of primary liver cancer, consisting of hepatocellular carcinoma and cholangiolocellular carcinoma, arising in alcoholic liver disease (2010) (3)
Contrast-enhanced ultrasonograpic studies on pancreatic carcinoma with special reference to staining and muscular arterial vessels. (2014) (3)
Temporary indwelling catheter system via the left brachial artery: evaluation in 83 patients with hepatic tumors. (2007) (3)
[A case of cat scratch disease identified by an elevated Bartonella henselae antibody level using enzyme immunoassay]. (1997) (2)
Decreased regional cerebral blood flow during interferon therapy (1997) (2)
Peginterferon‐alpha‐2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi‐institutional questionnaire in Japan (2010) (2)
Antibodies to hepatitis C virus in non-A non-B fulminant viral hepatitis (1990) (2)
Dextromethorphan for neuropathic pain with Churg–Strauss syndrome (2001) (2)
Electron Spin Resonance Study on Lipopolysaccharide-Induced Membrane Damage in Erythrocytes (1990) (2)
Functional liver imaging with asialoglycoprotein receptors and serum hyaluronate in a patient with amyloidosis (1995) (2)
Effect of transcatheter arterial chemoembolization on kidney hemodynamics and function in patients with cirrhosis and hepatocellular carcinoma. (1999) (2)
[Forefront of therapy for hepatic fibrosis]. (2002) (2)
CLINICAL APPLICATION OF SERUM HYALURONAN FOR LIVER DISEASES AND ITS SIGNIFICANCE (2002) (2)
B-Flow contrast US with Levovist in hepatic tumors: preliminary results. (2003) (2)
A case of evolvement to HBV carrier after receiving blood positive for HBsAg. (1988) (2)
Clinical significance of serum HBVDNA detected by the PCR method. (1993) (2)
Therapeutic effects of restricted diet and exeicise is of benefit to patients with non-alcoholic steatohepatitis (NASH) (2003) (2)
Phase II Trial of Hepatic Arterial Infusion Chemotherapy Using Cisplatin and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma (2000) (2)
[A case of IgG4-related sclerosing disorders involving the mesentery and the pancreas]. (2011) (2)
Univariate Analysis to Examine Predictors of Response to Leukocytapheresis in Ulcerative Colitis Patients (2014) (2)
Involvement of P21WAF1/CIP1 and P27KIP1 in troglitazone-induced cell cycle arrest in human hepatoma cell lines (2000) (2)
Killing two birds with one treatment. (1997) (2)
Anti-HBc in hepatocellular carcinoma without HBsAg, HBV DNA, anti-HCV, and HCV RNA. (2000) (2)
A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis. (2005) (2)
Two Cases of SuspectedBartonella henselaeInfection from a Dog (1999) (2)
Quantitative studies on the impaired filterability of erythrocytes from patients with liver cirrhosis (2005) (2)
Characteristics and Outcomes of HCV Genotype-1-Infected Patients Treated with Peginterferon and Ribavirin Combination Therapy with Discordant HCV Responses 4 and 12 Weeks after Starting Therapy (2014) (2)
Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders. (2006) (2)
Confocal laser microscopy of chondrocytes that received gene transfer using in vitro electroporation. (2002) (2)
Clinical Benefits and Cost-Effectiveness of 17-Year Treatment with Low-Dose Interferon-α 2b in a Patient with Chronic Hepatitis C: A Case Report (2009) (2)
Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1 c in adipose tissue (2)
Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis and CAPD. (1993) (2)
Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B. (2002) (2)
[A case of mesenteric cavernous hemangioma showing interestingly image study]. (2005) (2)
Keratin inclusions alter cytosolic protein localization in hepatocytes (2007) (2)
GB virus infection in acute and chronic cryptogenic liver disease. (1997) (2)
[Disappearance of basal ganglia hyperintensity on T1-weighted MR images after obliterating portal systemic shunt in a patient with hepatic encephalopathy]. (2002) (2)
Decreased serum levels of immunoglobulin A, immunoglobulin M and immunoglobulin G in a patient with primary biliary cirrhosis: A case report (2014) (2)
Branched-Chain Amino Acid Supplementation Complements Conventional Treatment for Spontaneous Bacterial Peritonitis (2006) (2)
Factors associated with sustained virological response in 24‐week telaprevir‐based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype (2015) (2)
Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis (2002) (2)
Lack of anti‐GOR antibody among subjects with GB virus C/hepatitis G virus RNA (1998) (2)
Antineoplaston AS2-1 for maintenance therapy in liver cancer. (1997) (2)
[Glucose metabolism disorder: a risk factor for hepatocellular carcinoma]. (2012) (2)
Low-dose oral interferon-α in the treatment of chronic viral hepatitis type B: A double-blind, randomized, placebo-controlled, clinical trial (2000) (2)
Serum levels of IgG to the peptide of HCV1b core at positions 35–44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132–2140 correlated with better prognosis in HCV-infected patients (2007) (2)
Peginterferon ALPHA-2A (40KD) Plus Ribavirin for the Treatment of Patients With Chronic Hepatitis C (CHC) and Compensated Liver Cirrhosis in Japan (2011) (2)
[Immunological studies on the patients with Crohn's disease and a new attempt of interferon treatment]. (1989) (2)
A CASE OF PANCREATIC SEROUS CYSTADENOMA SHOWING INTERESTING IMAGE STUDIES (2006) (2)
Transarterial infusion chemotherapy alone versus transarterial chemoembolization for the treatment of hepatocellular carcinoma: Results of a multicenter randomized phase III trial (2007) (1)
1304 PEPTIDES PRODUCED BY AUTOLYSIS REACTIONS FROM WHEAT BRAN HAVE THERAPEUTIC EFFECTS IN NONALCOHOLIC STEATOHEPATITIS (2013) (1)
Pharmacokinetics and Safety of DS-8500a, an Antidiabetic Drug, in Japanese Subjects with Hepatic or Renal Impairment: A Single-Center, Open-Label, Single-Dose Study (2018) (1)
Involvement of GBV-C/HGV in liver diseases in Japan (1999) (1)
Analysis of the factors motivating HCV-infected patients to accept interferon therapy (2012) (1)
[Obesity and liver diseases]. (2006) (1)
Development of intrahepatic cholangiocarcinoma after a 14‐year follow‐up of a patient with primary sclerosing cholangitis and ulcerative colitis (2011) (1)
Endoscopic Ultrasonography of Autoimmune-Related Pancreatitis in Five Cases: The Reticular Pattern Disappears After Steroid Therapy? (2005) (1)
Correction: Quantification of Hepatic Iron Concentration in Chronic Viral Hepatitis: Usefulness of T2-weighted Single-Shot Spin-Echo Echo-Planar MR Imaging (2012) (1)
[A case of chronic hepatitis type B with Crohn's disease]. (1986) (1)
Clinical usefulness of serum HBV DNA measurement with a non radioactive chemiluminescence method (1997) (1)
[HCV and extrahepatic manifestations]. (2004) (1)
Effectiveness of 6-month intermittent administration of natural human interferon-alpha against non-A non-B chronic hepatitis. (1992) (1)
1284 CIRRHOSIS DEVELOPMENT ASSOCIATED WITH ELEVATED SERUM IGG4 IN TYPE I AUTOIMMUNE HEPATITIS (2011) (1)
Acute onset autoimmune hepatitis in pregnancy complicated with fetal ascites: A case report (2013) (1)
Does hepatocellular carcinoma develop after treatment of Wegener's granulomatosis with cyclophosphamide? (2003) (1)
Successful Treatment With Corticosteroid and Lamivudine for Autoimmune Hepatitis in a Patient With Asymptomatic HBV Infection (2007) (1)
A crossover study of oral administration of UFT in chronic liver disease: comparison of continuous and intermittent schedules. (1998) (1)
[Epidemiologic study of HAV and HBV infections in persons in various environments]. (1985) (1)
Contraction and Relaxation of Ito Cells (1999) (1)
Study of immunoglobulin M antibody against hepatitis B core antigen in patients with HBV infection. (1986) (1)
[Endoscopic and radiological diagnosis of early colorectal cancer]. (2003) (1)
[Extrahepatic manifestation associated with HCV infection]. (1999) (1)
A patient with hyperlipidemia who had a gallbladder stone caused by administration of fenofibrate. (2003) (1)
High prevalence of anticardiolipin antibodies and platelet-associated immunoglobulin G in hepatitis C virus infection (2000) (1)
Thyroid dysfunction induced by interferon therapy for the treatment of hepatitis type C. A report of 4 cases. (1995) (1)
テガフール・ギメラシル・オテラシルカリウム配合カプセル剤(TS-1)が奏効した肝細胞癌の1例 (2003) (1)
A case of acute exacerbation of chronic hepatitis B accompanied by antibody to HBeAg with remission of liver damage after long-term treatment with interferon. (1995) (1)
Hypoxia-inducible factor 1B contributes to the early stages of angiogenesis in human hepatocellular carcinoma (2000) (1)
Abstract 2746: Thiazolidinediones augment anticancer effects of gemcitabine on human pancreatic cancer cells through PPARδ activation (2012) (1)
Observation of liver tissue damage after radiofrequency ablation by electron microscope (2000) (1)
Nuclear DNA fragmentation in biliary epithelial cells and in hepatocytes in primary biliary cirrhosis (1995) (1)
Sequential interferon-alpha and beta treatment in patients with chronic hepatitis C. (1996) (1)
Retrospective Proteomic Analysis of a Novel, Cancer Metastasis-Promoting RGD-Containing Peptide (2017) (1)
[Study of serum 2-5AS activity and NK cell activity in the patients with Crohn's disease and ulcerative colitis]. (1988) (1)
Secretory IgA anti-HAV in saliva of hepatitis A patients (1998) (1)
Mo1400 Endoscopic Ultrasound (EUS) Findings of the Pancreatic Parenchyma in Autoimmune Pancreatitis, Including Changes Before and After Steroid Therapy (2011) (1)
Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia (2019) (1)
A SUCCESSFUL REPLACEMENT OF MIGRATED DRAINAGE TUBE IN THE PANCREATIC CYST DURING ENDOSCOPIC CYSTOGASTROSTOMY (2004) (1)
Epidemiologic study of anti-HCV antibody reactivity with immunoblot assay (1997) (1)
[A case of drug induced liver injury related pioglitazone]. (2003) (1)
Author and Subject Index (1998) (1)
Prophylactic effect of peptide vaccination against hepatocellular carcinoma associated with hepatitis C virus (2010) (1)
Portal hypertension with liver cirrhosis causes reduced contraction and histological changes in gallbladder (1995) (1)
Evaluation of first- and second-generation assays for detection of antibody to hepatitis C virus in non-A, non-B chronic liver diseases--evaluation of 1st and 2nd-generation assays in NANBH. (1993) (1)
Transarterial chemoembolization as salvage therapy after unsuccessful hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma. (2008) (1)
Evaluation of Individual Care of Patients by Medical Students for Attitude Education. (2001) (1)
Symposium on clinical aspects in hepatitis virus infection. 6. Hepatitis virus and extrahepatic manifestions--skin, mucosa, muscle, and hematopoietic organs. (2001) (1)
Eicosapentaenoic Acid (EPA) Attenuates the Anemia Due to Ribavirin/Interferon a Treatment in Patients with Chronic Hepatitis C. (2004) (1)
Graves' ophthalmopathy and tongue cancer complicated by peg-interferon α-2b and ribavirin therapy for chronic hepatitis C: A case report and review of the literature. (2008) (1)
Protective Erects of Bile Acids against Lipopolysaccharide-Induced Membrane Fragility in Rat Erythrocytes (1991) (0)
90-124 Prospective study about depressive state following interferon administration (1997) (0)
Enhanced sensitivity to insulin-like growth factors in SLUG-induced epithelial-mesenchymal transition (2007) (0)
Activity in Cirrhotic Rat Liver (1995) (0)
Angiogenesis of Cultured Rat Sinusoidal Endothelial Cells (1999) (0)
Intracellular traffic of asialoglycoproteins depends on vacuolar pH in polarized isolated rat hepatocyte couplets (1999) (0)
Study on increased immunoglobulin A in alcoholic liver disease. Analysis of serum secretory and dimeric IgA and IgA containing cells in the lamina propria of the colon. (1988) (0)
Tc-99m-GSA liver scintigraphy in alcoholic liver cirrhosis (2003) (0)
The case of an elderly male patient with autoimmune hepatitis complicated by various immunological abnormalities (2010) (0)
W1863 Niemann-Pick C1 Protein Transports Copper to the Secretary Compartment from Late Endosomes Where Atp7b Resides (2008) (0)
OVEREXPRESSION OF MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE (MT1-MMP), MATRIX METALLOPRATEINASE-2 (MMP-2) IS ASSOCIATED WITH TUMOR DEVELOPMENT IN HEPATOCELLULAR CARCINOMA (HCC). (2001) (0)
598 THE INCIDENCE OF HEPATOCELLULAR CARCINOMA ASSOCIATED WITH HEPATITIS C INFECTION DECREASED IN KYUSHU, JAPAN (2010) (0)
Inhibitory effects of an herbal medicine “sho-saiko-to” on PDGF-BB induced tyrosine phosphorylation and cell proliferation in human hepatic stellate cells (2001) (0)
Kupffer cell function and endotoxin. (1992) (0)
Peptide epitope of an antibody of the reagent crohn and to test crohn's disease. (2005) (0)
The Effect of MMP-3 on the Degeneration of Intervertebral Discs (1998) (0)
A patient of hepatocellular carcinoma with marked jaundice from pancreatitis treated effectively with PGE 1 via hepatic artery (2001) (0)
1005 Estimating the benefit of interferon therapy for individual patients with chronic hepatitis (2003) (0)
Mo1435 Magnifying Endoscopic Observation of Non-Neoplastic Bile Duct Mucosa: Comparison of Narrow Band Imaging With Histopathology (2011) (0)
Present Status and Future of Gene Therapy for Hepatic Fibrosis (2001) (0)
Abstract 3934: HCV core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-α/hypoxia-inducible factor-1α axis under hypoxic conditions (2012) (0)
699 Nateglinide improves non-alcoholic steatohepatitis (NASH) with type 2 diabetes (2006) (0)
Abstract 890: Human TCF-4 isoforms regulate apoptosis through upregulating Bcl-xL expression in a SxxSS motif-dependent manner. (2013) (0)
Abstract 330: The Wnt signal transcription factor TCF-4 directly regulates Bcl-xL expression in human hepatocellular carcinoma cells (2014) (0)
Management Strategies for Autoimmune Hepatitis Treatment Nonresponders (2014) (0)
Subject Index Vol. 117, 2007 (2007) (0)
Asialoglycoprotein receptor function of hepatocytes in patients with autoimmune hepatitis. (1994) (0)
[Two-color flow cytometric analysis on human peripheral blood T-lymphocytes using monoclonal antibody BM-1 directed to Le(Y) determinant structure]. (1991) (0)
[775] OVEREXPRESSION OF PIGMENT EPITHELIUM-DERIVED FACTOR PREVENTS FAT STORAGE, INFLAMMATION AND NEOPLASTIC FORMATION IN THE LIVER OF MICE STEATOHEPATITIS MODEL (2007) (0)
[Recent clinical characteristics of hepatitis A]. (2011) (0)
Increased Awareness of the Possibility of HBV Reactivation Through Use of Patient HBV Caution Cards (2016) (0)
Development of granulocyte and monocyte adsorptive apheresis in the rat dextran sodium sulfate-induced colitis model. (2007) (0)
Peroxisome proliferator-activator receptor-α activator (PPAR-α) dose not inhibit the activation of human hepatic stellate cells by IL-1β (2003) (0)
[Routes of transmission of hepatitis C virus in hyperendemic areas, and molecular epidemiologic study of hepatitis C virus infection]. (2004) (0)
Cholestasis and Hepatic Sinusoidal Cells (1999) (0)
Abstracts of selected papers presented at the 29th annual meeting of the Japanese society of gastroenterology Kofu, Japan, November 5–7, 1987 (1988) (0)
491 Estrogen upregulates nitric oxide production via estrogen receptor alpha of hepatic sinusoidal endothelial cells in cirrhosis (2003) (0)
Hepatic Innervation and Hepatic Sinusoidal Cells (1999) (0)
356 RECENT PROGRESS IN MANAGEMENT OF HEPATOCELLULAR CARCINOMA DIAGNOSED DURING SURVEILLANCE IN JAPAN (2008) (0)
Contents Vol. 117, 2007 (2007) (0)
Fungus thielavia minor blocks hepatic stellate cell proliferation and inhibits experemental hepatic fibrosis in rats (1998) (0)
The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C. (2012) (0)
Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus (1999) (0)
Second generation amplicor HCV monitor assay, clinical features and predictors of the response to interferon (2000) (0)
Suppression of transforming growth factor-β effects up-regulates expression of regeneration factors in liver cirrhosis (2003) (0)
Role of PPAR-Г in a murine experimental colitis (2000) (0)
The sequential analysis of the precore region of HBV-DNA during lamivudine therapy in homogeneous patients infected with HBV genotype C in Japan (2003) (0)
Efficacy of flumazenil, a benzodiazepine antagonist, in patients with alcoholic liver cirrhosis complicating hepatic encephalopathy. (1997) (0)
Propranolol ameliorates hypersplenism in patients with cirrhosis (2000) (0)
Mo1342 In Vitro Magnifying Endoscopic Observation of Non-Neoplastic Bile Duct Mucosa: Comparison of Endoscopic Findings With Histopathology (2012) (0)
A case of acute hepatitis type A with muscular involvement (2009) (0)
Molecular mechanism on cell proliferative suppression of TGF-bå@forå@hepatoma cell (2000) (0)
[Clinical evaluation of the relationship between interferon therapy and oral lichen planus in patients with type C chronic hepatitis]. (2000) (0)
[Genotypic classification and molecular epidemiology of hepatitis A virus]. (1995) (0)
[The prevention of hepatitis B virus (HBV) infection by passive immunization (HBIG) in accidental exposures]. (1987) (0)
Abstracts of selected papers presented at the 74th general meeting of the Japanese Society of Gastroenterology (2007) (0)
[Five cases of erythema infectiosum in adults]. (2001) (0)
comparative Study Of Mutations Of Hcv Ires Is Useful For The Prediction Of The Effectiveness Of The Pegylated Interferon/ribavirin Combination Therapy For Chronic Hepatitis C : 1044 (2010) (0)
Function of asialoglycoprotein receptor of hepatocytes in patients with Wilson's disease. (1994) (0)
Diagnosis and Treatment of Hepatic Fibrosis and Hepatic Sinusoidal Cells (1999) (0)
CHANGES OF CELL, EXTRACELLULAR MATRIX, APOPTOSIS AND ANGlOGENESIS IN HEPATIC INJURY AND REPAIR (2001) (0)
Front & Back Matter (2012) (0)
301 AN ASSOCIATION BETWEEN USE OF SULFONYLUREAS OR EXOGENOUS INSULIN AND THE PRESENCE OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C PATIENTS WITH DIABETES MELLITUS (2008) (0)
[A follow-up study after HB vaccination for children]. (1987) (0)
RHO SIGNALING IS REQUIRED FOR MECHANICAL STRETCH-INDUCED TGF-β PRODUCTION IN HEPATIC STELLATE CELLS (2001) (0)
An outbreak of acute hepatitis, type A at an orphanage in Oita city (1980) (0)
Characterization of Circulating Monoclonal B Lymphocytes in Patients with HCV Infection (2008) (0)
[Fostering future gastroenterology specialists -initiatives and challenges of medical gastroenterology-]. (2012) (0)
Erratum to: A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis (2010) (0)
Effective extracorporeal shock wave lithotripsy for pancreatic duct stone. (2003) (0)
[Longitudinal study of serological response to Bartonella henselae by indirect fluorescence assay in cat scratch disease]. (2001) (0)
Pigment Epithelium-Derived Factor (PEDF) Inhibits Multiple Myeloma through Suppressing NADPH Oxidase ROS Generation. (2005) (0)
Titles of papers presented at the 66th annual meeting of the Japanese Society of Gastroenterology, March 30–April 1, 1980, Tokyo, Japan (2008) (0)
[A case of hepatocellular carcinoma treated with TS-1]. (2003) (0)
Abstracts of selected papers presented at the 30th Annual Meeting of the Japanese Society of Gastroenterology October 20–22, 1988 — Kagoshima, Japan (1991) (0)
Sequential Interferon-ƒ¿ and ƒÀ Treatment in Patients with Chronic Hepatitis C (1996) (0)
Have development of treatment improved outcome of patients with bleeding gastric varices (2000) (0)
[Evaluation of serological response to Bartonella henselae by enzyme immunoassay in cat scratch disease]. (2000) (0)
Enhanced US (levovist) using B-Flow of the liver tumors. (2000) (0)
The intrinsic inhibitors of JAK/STAT pathway, CIS3/SOCS3/SSI3 and JAB/SOCS1/SSI1, play a negative regulatory role in STAT3 activation and intestinal inflammation (2001) (0)
Natural Killer Cells in the Liver and Their Activators (1999) (0)
259 Endothelial progenitor cells contribute to neovascularization in liver regeneration after liver injury (2003) (0)
The effect of a continuous administration of a benzodiazepine antagonist (flumazenil) to the hepatic encephalopathy in alcoholic liver cirrhosis (2003) (0)
Duration of chronic HCV infection and efficacy of interferon in chronic hepatitis C patients with a history of blood transfusion. The Study Group for Treatment of Hepatitis in the Kyushu Area. (1997) (0)
590 Tracing the pandemic behavior of hepatitis C virus genotype 1B in Japan — association with the widespread injection treatment for schistosomiasis (2003) (0)
ANTI-TGF-β INTERVENTION INHIBITS PROGRESSION OF HEPATIC FIBROSIS (2001) (0)
Endoscopic Differences of Gastric Cardiac Varices from Fundal Varices in Acute Bleeding (2006) (0)
Abstracts of selected papers presented at the 33rd Annual Meeting of the Japanese Society of Gastroenterology (2007) (0)
Recombinant beta glucocerebrosidase changed the ultrastructure of Gaucher cells associated with biochemical improvement in Gaucher disease (2000) (0)
Subject Index Vol. 116, 2006 (2006) (0)
chronic hepatitis C carcinoma prevention for individual patients with Benefit of interferon therapy in hepatocellular (2004) (0)
Tu1814 GLP-1R Agonist Increased Glucose Uptake and Inhibited GSK3ß Phosphorylation Through the AMPK Signaling Pathways in Human Hepatocytes (2012) (0)
[Hepatic injury of acute hepatitis A]. (1995) (0)
The New Therapeutic Approach for Inflammatory Bowel Disease Using Antisense Macrophage-Migration Inhibitory Factor (MIF) / Schizophyllan (SPG) Complex (2011) (0)
Long-term progress of patients with chronic hepatitis B after administration of Lamivudine. (2002) (0)
Abstract 289: Inhibition of Trk receptor leads to mesenchymal-epithelial transition in human hepatocellular carcinoma cell lines. (2013) (0)
[Serum HCV-RNA for evaluation of interferon-readministration to the former non responders in chronic hepatitis C]. (1994) (0)
Discovery and Clinical Application of Human Bone Metastasis Biomarker (2006) (0)
S1967 Oxidized Albumin Is Associated with Water Retention and Severity of Disease in Patients with Liver Cirrhosis (2008) (0)
[Apoptosis and fulminant hepatitis]. (1995) (0)
Isolation and culture of intrahepatic biliary epithelial cells from the normal rat liver. (1990) (0)
Acute hepatitis type C co-infected with GBV-C treated with interferon. (1996) (0)
Lymphocyte progenitors in CD8AA expressing intestinal intraepithelial lymphocytes are derived from neonetal appendix (2000) (0)
OK-432 enhances the expression and activity of matrix metalloproteinase-9 in rat Kupffer cells and suppresses rat experimental hepatic fibrosis (1998) (0)
311 EX VIVO-EXPANDED PERIPHERAL CD34+ CELLS FOR CHRONICALLY INJURED LIVER TREATMENT: IN VITRO AND IN VIVO STUDIES (2013) (0)
Evaluation of third generation anti-HCV test kit (SYNPEP HCV-EIA II) using sera of inhabitants from HCV hyperendemic area. (1998) (0)
Evaluation ofintestinal permeability inpatients withinflammatory boweldisease using lactulose andmeasuring antibodies tolipid A (1995) (0)
Su1402 Ex Vivo Magnifying Endoscopic Observation of Bile Duct Mucosa Using Narrow Band Imaging and Acetic Acid (2013) (0)
Lamivudine Therapy of Hepatitis B in Japan (2004) (0)
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Analysis of 160 patients (2003) (0)
Portal hypertension and black gallstone formation in cirrhosis (1995) (0)
High Prevalence of HCV Infection in Patients with Oral Cancer and Oral Precancerous Lesion (1999) (0)
Combination therapy with interferona and Гincreases host immune response in patients with chronic hepatitis C (2000) (0)
P459 Rescue Therapy by Autologous Infusion of Granulocyte-Colony Stimulating Factor-Mobilized Peripheral Blood Cd34-Positive Cells in Patients With Decompensated Liver Cirrhosis (2014) (0)
432 Correlation between mutational patterns in HBV polymerase region and the severity of breakthrough hepatitis during lamivudine therapy (2004) (0)
[Hepatitis C acquired through drug abuse among young generations]. (2002) (0)
Phosphatidylinositol 3-kinase is required for mechanical stretch-induced TGF-b synthesis in hepatic stellate cells (2000) (0)
[Role of appendix in ulcerative colitis]. (2001) (0)
Title Page / Contents / Members of the Symposium / Preface / Introductory Remarks (2001) (0)
[Prognosis and follow-up study of chronic hepatitis]. (1994) (0)
Awareness Survey of Prejudice and Discrimination (2017) (0)
[Hepatic iron overload]. (1995) (0)
A pilot study of natural interferon γ therapy for chronic hepatitis C (1997) (0)
Systemic sclerosis associated with diabetes insipidus. (1997) (0)
Morphological analysis on apoptosis and angiogenesis in the repair of hepatic fibrosis (2002) (0)
Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia. (2003) (0)
Significance of prognostic prediction and cost-benefit-analysis in intensive therapy in fulminant hepatitis. (1998) (0)
Efficacy of surveillance for early detection of hepatocellular carcinoma among patients with HBsAg positive chronic liver disease. (2001) (0)
[Hepatitis C virus infection in alcoholic patients with chronic liver disease]. (1995) (0)
[Epidemiological trend of hepatitis type A in Japan]. (1995) (0)
1023 COMPARISON OF TIME TO PROGRESSION BETWEEN SINGLE TACE AND HEPATIC ARTERIAL INFUSION CHEMOTHERAPY PRIOR TO TACE FOR THE PATIENTS WITH MULTINODULAR HEPATOCELLULAR CARCINOMA (2012) (0)
[Molecular epidemiology of HCV in hyperendemic area]. (1995) (0)
1053 A NOVEL SYNTHETIC SULFOGLYCOLIPID SULFOQUINOVOSYLACYL PROPANEDIOL (SQAP) SWITCHES OFF TUMOR ANGIOGENIC POTENTIAL OF HEPATOCELLULAR CARCINOMA THROUGH THE UPREGULATION OF VON HIPPEL–LINDAU PROTEIN (2013) (0)
Mo2005 Leukocytapheresis Enhances Colonic Blood Flow Through the Up-Regulation of CGRP Production in the Rat Colitis Model (2012) (0)
1177 Predicting relapse after cessation of lamivudine monotherapy for chronic hepatitis B virus infection-application of newly developed HBV real-time detection direct test (2003) (0)
Abstract 4248: Antiangiogenic mechanisms of Aflibercept in mouse hepatoma model (2011) (0)
Gastrointestinal , Hepatobiliary and Pancreatic Pathology Pigment Epithelium-Derived Factor Inhibits Lysosomal Degradation of Bcl-xL and Apoptosis in HepG 2 cells (2010) (0)
[Total colon stricture in ulcerative colitis with various extrantestinal manifestations]. (2002) (0)
Tumor doubling time and vascularity predict prognosis of patients with small hepatocellular carcinoma in Japan (2002) (0)
Long-term improvement of hepatic fibrosis in chronic hepatitis C treated with interferon-α (1998) (0)
Pathogenesis and Significance of Restricted Diet and Exercise Therapy in Nonalcoholic Steatohepatitis (NASH) (2005) (0)
Activation of Il6/Stat3/Cis3 signaling pathway in the development of intestinal inflammation in samp 1/Yit mice (2003) (0)
An endothelin receptor antagonist improves portal hypertension and hepatic blood flow in experimental cirrhotic rats (1998) (0)
Abstract 1047: The multikinase inhibitor K252a suppresses hepatocellular carcinoma tumor growth in a mouse xenograft model (2014) (0)
P105 PLASMA ACYL GHRELIN REPRESENTS A DIFFERENCE OF NUTRITIONAL METABOLISM BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS (2008) (0)
Subject Index Vol. 46, 2003 (2003) (0)
Epigallocatechin gallate prevents cell proliferation of hepatic stellate cells due to blockade of PDGF binding to its receptor in a non-competitive manner (2002) (0)
Taste Alteration in Palliative Care (2011) (0)
Contents Vol. 116, 2006 (2006) (0)
Impaired filterability of erythrocytes from patients with chronic hepatitis under combined treatment with interferon and ribavirin: Rheologic effects of eicosapentaenoic acid (2006) (0)
Superoxide anion generation in polymorphonuclear leukocytes obtained from rats with galactosamine-induced hepatic injury (1990) (0)
The relationship between LeY antigen and the therapeutic efficacy of interferon in chronic hepatitis C. (1993) (0)
The Role of Neutrophils in Liver Cell Injury in Alcoholic Hepatitis (1999) (0)
852 A MUTATIONAL ANALYSIS OF THE INTERNAL RIBOSOME ENTRY SITE IN HEPATITIS C VIRUS IN PATIENTS TREATED WITH PEGYLATED INTERFERON WITH RIBAVIRIN (2008) (0)
A study of erythrocyte C3b receptors (E-CR1) in patients with acute viral hepatitis. (1993) (0)
513 Gene transfer of K1-5 suppresses the growth of hepatocellular carcinoma (2003) (0)
Clinical Efficacy and Potentiality in Leukocytapheresis for the Treatment of Inflammatory Bowel Disease (2009) (0)
107 Transplantation of endothelial progenitor cells improves carbon tetrachloride (CCL4)-induced liver cirrhosis in rats (2006) (0)
[A periappendiceal abscess during combination interferon and ribavirin treatment for chronic hepatitis C]. (2007) (0)
796 USE OF EXOGENOUS INSULIN OR SULFONYLUREA ASSOCIATED WITH AN INCREASED INCIDENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS C VIRUS INFECTION (2009) (0)
[New management of hepatitis B virus]. (1999) (0)
Study of Reflectance Spectrophotometric Analysis on Intraarterial Injection (1987) (0)
Abstract 2309: Hepatitis C virus core protein in combination with interleukin-6 induces epithelial-mesenchymal transition through upregulation of Snail and E2A in human hepatocyte-derived cells (2010) (0)
[Causes of liver cirrhosis and clinical statistics on HCV associated liver cirrhosis]. (1995) (0)
Tu1628 Action of Leukocytapheresis Depends on Calcitonin Gene-Related Peptide in Colitis Models (2013) (0)
[A case of chronic hepatitis C virus-related advanced hepatocelluar carcinoma surviving more than 8 years]. (2007) (0)
Expression of CIS3/S0CS-3 in colitis and its regulatory role in STAT3 activation (2000) (0)
P107 Action of leukocytapheresis is associated with calcitonin gene-related peptide induction in colitis models (2013) (0)
A case of liver failure due to long-term ingestion of acetaminophen. (1991) (0)
P-137 Hepatocytotic clearance of lipopolysaccharide in chronically alcohol-fed rats (1995) (0)
Abstract 3050: Human rectal carcinoid tumors highly express DCLK1, a putative cancer stem cell marker (2014) (0)
New treatments for hepatitis B viruses. (1999) (0)
Proceedings of the 69th General Meeting from April 11–13, 1983-Osaka, Japan (1984) (0)
[601] DOUBLE FILTRATION PLASMAPHERESIS AND (PEG) INTERFERON/RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C PATIENTS (2007) (0)
Abstract 1389: Low dose metronomic chemotherapy of S-1 and Vandetanib produces nontoxically good therapeutic results for hepatocellular carcinoma (HCC) (2010) (0)
[A case of advanced hepatocelluar carcinoma achieving a complete response following the hepatic arterial infusion chemotherapy and subsequent lipiodolization]. (2003) (0)
Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study (2012) (0)
Reports of Viral Contamination Occurred in Kurume University Hospital (1995) (0)
Three-year assessment of entecavir resistance in chronic hepatitis B patients and the mechanism of viral breakthrough by the resistance substitutions (2008) (0)
P407 Predictive factors for the efficacy of leukocytapheresis in ulcerative colitis (2013) (0)
A case of HBsAg seroclearance by readministration of lamivudine and adefovir dipivoxil in patient with liver cirrhosis due to hepatitis B virus infection (2014) (0)
A Case of Amebic Liver Abscess with HIV Carrier (2002) (0)
P189 HANDGRIP STRENGTH IS USEFUL AND EASY ITEM FOR SCREENING OF NUTRITIONAL ASSESSMENT IN PATIENTS WITH LIVER CIRRHOSIS (2009) (0)
Truncated type II TGF-beta receptor promotes liver regeneration in dimetylnitrosamin-treated cirrohotic rats (2002) (0)
RESOLUTION OF LIVER FIBROSIS IN HEPATITIS C PATIENTS WITH INTERFERON : A NATIONAL SURVEY (2001) (0)
The effect of a multiple drug therapy with Inchinkoto, a herbal medicine on bile acids and bilirubin in two patients with prolonged severe mixed type of drug induced liver injury (2012) (0)
MANAGEMENT AND PROBLEM OF ENDOSCOPIC BILIARY DRAINAGE (2006) (0)
Immunological study of the association between hepatocyte damage and HBc antigen. (1992) (0)
803 ADIPONECTIN EXPRESSED IN LIVER DIRECTLY IMPROVES NONALCOHOLIC STEATOHEPATITIS (NASH) BY WAY OF ANTI-INFLAMMATION AND ANTI-OXIDATIVE STRESS (2010) (0)
[Arterial infusion chemotherapy for patients with advanced pancreatic cancer]. (2006) (0)
Effect of angiographic sclerotherapy on portal pressure and liver function in patients with cirrhosis (2000) (0)
GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan (1997) (0)
Contents Vol. 46, 2003 (2003) (0)
[A study on hepatic dysfunction associated with rubella infection]. (1991) (0)
Survival benefit in hepatocellular carcinoma patients with portal vein tumor thrombosis treated by hepatic arterial infusion chemotherapy (2002) (0)
Erratum to: Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michio Sata?

Michio Sata is affiliated with the following schools:

Kurume University